SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.
Nautilus’ management is scheduled to present on Wednesday, September 15th at 1:15 p.m. Eastern Time/10:15 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the company’s website at: https://www.nautilus.bio/investors/
About Nautilus Biotechnology, Inc.
Nautilus is a biotechnology company who is developing a proteomics platform that aims to deliver superior sensitivity more quickly, more completely, and less expensively than is currently possible. Nautilus Biotechnology aims to enable a dramatic acceleration of basic science research, significantly improve the success rate of therapeutic development, and enhance opportunities for personalized and predictive medicine. Nautilus’ corporate headquarters is in Seattle, Washington and scientific research and development is being conducted from its San Carlos, California office and labs.
Contacts
Investors:
InvestorRelations@nautilus.bio
Media:
Chris Blessington
Vice President, Corporate Marketing and Communications
chrisb@nautilus.bio
Government and industry have tried and failed to stem the overdose epidemic for more than…
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Post-Traumatic Stress…
eClinicalWorks successfully completes UDS+ FHIR® synthetic testing and begins FQHC voluntary testingWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the…
Report Reveals Key Factors Shaping the Healthcare Recruitment and Retention LandscapeNEW YORK, NY / ACCESSWIRE…
Sustained acoustic medicine technology from ZetrOZ Systems eliminates veteran's severe knee pain without surgery or…
Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…